Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia
['Acute promyelocytic leukaemia', 'All-trans retinoic acid', 'Arsenic trioxide', 'Long-term survival']
